EUVIMED · CrossrefJournal
JCO Oncology Advances
ISSN 2994-9750 · American Society of Clinical Oncology (ASCO)
Latest articles
Immersive Virtual Reality for the Management of Chemotherapy-Induced Distress in Patients With Cancer
Concordance of Somatic Whole-Exome Sequencing and Germline Genotyping of DPYD to Screen for Dihydropyrimidine Dehydrogenase Deficiency
GemSarc: A Novel Predictive Gene Signature for Gemcitabine Efficacy in Advanced Bone and Soft Tissue Sarcomas
NRG1 Fusion–Driven Pancreatic Cancer: Real-World Detection Across a Japanese National Database and International Genomic Datasets, With an Illustrative RNA-Confirmed Case
Neoadjuvant Lazertinib With or Without Chemotherapy in Patients With Resectable EGFR -Mutant Non–Small Cell Lung Cancer (NeoLazer): A Randomized, Multicenter, Phase II Trial
Single-Arm Combined Phase I/II Study Evaluating Limb Cryocompression to Prevent Chemotherapy-Induced Peripheral Neuropathy in Patients Receiving Taxane-Based Chemotherapy
Phase I Study of B440, an Oral Wilms' Tumor 1 Cancer Vaccine Using a Bifidobacterium Vector, in Patients With Metastatic Urothelial Cancer
Intismeran Autogene Therapy: An End-to-End Pathway From Tumor Tissue to Individualized Neoantigen Treatment for Patients With Cancer
LAPIS: A Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Neoadjuvant Pamrevlumab With Chemotherapy for Patients With Locally Advanced Pancreatic Cancer
Three-Year Update of a Randomized Phase IIb Study of the Individualized Neoantigen Therapy Intismeran Autogene (mRNA-4157, V940) Plus Pembrolizumab Versus Pembrolizumab in Resected Melanoma
Prescribing Patterns and Real-World Clinical Usage of Adjuvant Abemaciclib for Early-Stage, High-Risk, Estrogen Receptor–Positive Breast Cancer
Chemoradiation and Image-Guided Brachytherapy Alone or in Combination With Protease Inhibitor (Nelfinavir Mesylate) in Stage III Cervical Cancer: Results From a Phase III Trial
Trastuzumab Deruxtecan Is Active in Desmoplastic Small Round Cell Tumor
Long-Term Survival in High-Grade Serous Ovarian Cancer Compared With the General US Population: A 30-Year Landmark Analysis
PD-L2 Landscape and Correlation With Outcome: An Immunomic Analysis
Novel Blood-Based Liquid Biopsy Approaches in Hepatocellular Carcinoma
Functional Impact of Transoral Surgery and Risk-Based Adjuvant Therapy in Human Papillomavirus–Associated Oropharyngeal Cancer: Swallowing Outcomes From ECOG-ACRIN E3311
Gastric Adenocarcinoma in the United States: The Toll of Late Diagnosis and Racial and Geographic Disparities
ChatGPT Performance as Patient-Facing Triaging Tool in Oncology
Patient-Reported Outcomes During Pelvic Radiation Therapy: A Secondary Analysis on Sexual Function From NRG-RTOG 1203
Immune Checkpoint Blockade Therapies for Colorectal Cancer: Current Strategies and Emerging Approaches
SWOG 2308: Randomized Phase III Study of Mosunetuzumab Versus Rituximab for Low–Tumor Burden Follicular Lymphoma
Phase II Study of Ipilimumab, Nivolumab, and Panitumumab in Patients With KRAS / NRAS / BRAF Wild-Type Microsatellite Stable Metastatic Colorectal Cancer
State of Professional Well-Being, Satisfaction, and Career Plans Among US Oncologists in 2023
Selpercatinib Treatment Beyond Progression in RET Fusion–Positive Non–Small Cell Lung Cancer
Validation and Utility of Drug-Nutrient Interaction and Dietary Supplement Mechanistic Activity in the Natural Medicines Database
Differential Survival Among Patients With Cancer by COVID-19 Vaccination Status: An Analysis of the ASCO COVID-19 Registry
Nivolumab in Patients With Advanced or Metastatic Malignancies, Including Rare Cancers: Results of CheckMate 627, an Adaptive Basket Design Clinical Trial
Neoadjuvant Atezolizumab in Patients With Surgically Resectable Advanced Cutaneous Squamous Cell Carcinoma
Examining Racial Disparities in the Association Between Food Swamps and Early-Onset Colorectal Cancer Mortality
EUVIMED